
A federal judge in Vermont has ruled that a jury may, if the case proceeds to trial, decide whether the University of Vermont Medical Center mismanaged its retirement plan for employees. The case centers on allegations of underperforming funds and excessive fees inside a plan valued at $1.76 billion.
The ruling, reported Friday by Law360, found that a former worker had sufficiently backed up his request for a jury trial. That request now moves forward, meaning jurors could hear the case if it proceeds to trial rather than leaving the matter solely to a judge.
According to Bloomberg Law, the Vermont federal judge concluded that the plaintiffs primarily seek money damages rather than equitable relief, a distinction that matters because federal courts typically do not allow jury trials in ERISA class actions. Bloomberg Law reports that employees of University of Vermont Medical Center Inc. allege retirement plan mismanagement, and that the proposed class action they have brought primarily seeks money damages.
Why the Jury Question Matters
ERISA cases, which govern employer-sponsored retirement and benefit plans, usually unfold as bench trials decided by a judge. That is because the remedies available under the law have traditionally been considered equitable in nature, such as removal of fiduciaries and changes to plan terms, per Bloomberg Law's reporting. Equitable claims are historically the province of judges, not juries.
Because the judge in this case found that the plaintiffs are primarily after money damages, the calculus shifted enough to allow the jury trial request to proceed, according to the same Bloomberg Law report. The distinction between equitable relief and money damages is a recurring flashpoint in ERISA litigation nationally, since it can determine who ultimately decides the facts of a case.
What the Federal Law Says
The federal statute, 29 U.S.C. § 1132, is titled “Civil enforcement” and lists civil actions.
The allegations against the University of Vermont Medical Center remain just that — allegations. No liability has been established, and a jury could weigh the claims of underperforming investment funds and excessive fees inside the $1.76 billion plan if the case proceeds to trial.









